DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...
A method using light to measure blood glucose levels could save diabetes patients from frequent finger pricks every day.
Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...
Dexcom’s G6 (left) and G7 (right) side-by-side. [Image from Dexcom] A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose monitor ...
IEEE Spectrum on MSN
Why the most accurate glucose monitors are failing some users
In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings. The recall affects approximately 3 million sensors and was caused by an ...
WASHINGTON -- The U.S. Food and Drug Administration is warning people to stop using certain types of glucose monitor sensors after the company that makes them, Abbott Diabetes Care, said the devices ...
Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...
Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been linked to potential deaths.
The Insulet Omnipod 5 pump and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback